Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

KTTA - Pasithea Therapeutics Corp


Previous close
4.7104
0   0%

Share volume: 942
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$4.71
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023
Report Date 2022-05-16 2022-08-15 2022-11-14 2023-03-30 2023-05-12 2023-08-11 2023-11-13
Total revenue 13.658 K 13.581 K 218.608 K 240.712 K 0.000 0.000 0.000
Cost of revenue 12.937 K 15.101 K 86.465 K -1.308 K 0.000 0.000 0.000
Gross profit 721.000 -1.520 K 132.143 K 242.020 K 0.000 0.000 0.000
    -310.82% 8,793.62% 83.15% -100.00% nan% nan%  
Operating expenses 2.405 M 3.079 M 4.383 M 5.323 M 3.213 M 3.829 M 3.789 M
Selling general and admin 2.405 M 3.079 M 3.224 M 3.816 M 2.116 M 1.801 M 2.165 M
Research and development 0.000 0.000 1.159 M 1.506 M 1.096 M 2.028 M 1.625 M
Total expenses 2.418 M 3.094 M 4.469 M 5.322 M 3.213 M 3.829 M 3.789 M
    27.93% 44.47% 19.07% -39.63% 19.18% -1.03%  
Operating income -2.405 M -3.080 M -4.251 M -5.081 M -3.213 M -3.829 M -3.789 M
Ebit -2.405 M -3.080 M -4.251 M -5.081 M -3.213 M -3.829 M -3.789 M
Pretax income -1.574 M -2.658 M -4.586 M -5.118 M -3.266 M -3.598 M -3.613 M
    68.87% 72.52% 11.59% -36.19% 10.17% 0.40%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -1.574 M -2.658 M -4.586 M -5.118 M -3.538 M -3.763 M -3.613 M
    -68.87% -72.52% -11.59% 30.87% -6.38% 4.00%  
Net income -1.574 M -2.658 M -4.586 M -5.118 M -3.538 M -3.763 M -3.613 M
    -68.87% -72.52% -11.59% 30.87% -6.38% 4.00%